The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
Academic rigor, journalistic flair
Articles on RSV vaccine
Displaying all articles
Newly approved and updated vaccines are the best tools available to combat COVID-19, the flu and RSV, as infections and hospitalizations tick upward and cold and flu season gets underway.
Nearly 100,000 US children under age 5 are hospitalized each year for an RSV infection.
Even otherwise healthy children can end up in hospital with this winter respiratory virus.
The newly approved RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.
Top contributors
-
Associate Professor of Epidemiology, University of San Francisco
-
Research Nurse Coordinator, Murdoch Children's Research Institute
-
Senior Research Officer, Murdoch Children's Research Institute
-
Paediatric Respiratory Physician, and Honorary Fellow Manager, Murdoch Children's Research Institute
-
Associate Professor of Pediatric Infectious Diseases, Baylor College of Medicine
-
Associate Professor of Nursing, Purdue University
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
-
Professor of Infectious Diseases, Monash University
